Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Major Scottish gangland figure Steven Lyons arrested in Bali - 2SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- 3German mid-sized firms gloomy on outlook, survey finds
- 4Email Promoting Instruments for Compelling Efforts
- 5Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- Instructions to Augment the Presentation of Your Kona SUV
- Geomagnetic storm grounds launch of Mars space weather satellites
- Whale stranded off Germany for days found stuck again
- How to avoid or deal with an outrageous medical bill
- Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- Authorities arrest 7 bodyguards in connection with a Mexican mayor's assassination
- The 15 Most Powerful Forerunners in Business
